Real-world data published through 2025 and 2026 continues to confirm that many patients achieve and maintain clinically meaningful weight loss on semaglutide, even after previously being on tirzepatide
Some peptides are heavily promoted by anti-aging and weight loss clinics, including CJC-1295, Ipamorelin, and AOD-9604 , but unlike semaglutide or tirzepatide, they are not FDA-approved for obesity and lack strong clinical evidence
A provider can review your health history, adjust dosing if necessary, and determine whether GLP-1 treatment is the right approach for your goals
This allows for more gradual adjustments if you experience side effects or need fine-tuning of your treatment
However, the G1 and G4 groups showed a reduction in the activities of this enzyme (35 and 42% respectively) suggesting that substantial concentrations may have been used up in the process of combating oxidative stress as a result of the diabetic condition